Deepbridge Capital
Venture capitalChester · Seed–Growth · 18 people tracked
Investment thesis
Deepbridge Capital focuses on the growth capital market, sourcing, reviewing and actively managing portfolios of innovative companies in technology, life sciences and renewable energy. It targets seed-stage technology firms (SEIS), growth-focused technology and healthcare innovation companies (EIS), and asset-backed renewable energy generating assets. Investments are structured to leverage UK tax advantages under the Enterprise Investment Scheme and Seed Enterprise Investment Scheme. The firm emphasizes a sector-experienced team, thorough due diligence, hands-on management, and typically monthly deployments, working with investee companies throughout their funding journey with a focus on producing suitable exits. Fees are paid by investee companies, offering up to 100% tax efficiency for advised investors.
Source: firm website, verified Aug 3, 2026.
Team · 18 people
from the firm's website & public directoriesWhat they invest in
from 40 of 97 portfolio companiesHealthtech ×16Medical Devices ×12Biotech ×10AI & Machine Learning ×8Fintech ×6Deep Tech ×5Enterprise Software ×5Digital Health ×4
HQs:United Kingdom×16Australia×1European Union×1
Who they back
founder profiles across 11 portfolio companiesFounding team size:solo founder×52 founders×53 founders×1
Investments · 97 tracked
founders shown can be your intro pathFluoretiQ develops rapid point-of-care diagnostic tools that identify bacteria and determine effective antibiotics for veterinarians and clinicians, aiming to reduce reliance on empirical antibiotic treatment.
AgTechBiotechHealthtechMedical DevicesBristol, GB
Neciah Dorh(Co-founder & CEO)inJosephine Esposito-Elston(Founder & Co-inventor of NANOPLEX)
Co-investorsOxford Investment Opportunity Network (OION)
SaaS extreme event forecasting and synthetic data generation for machine learning.
Co-investorsAccess Venture PartnersAdit Ventures Management, LlcAgilitas Private EquityAlba Infra PartnersALIVE Israel HealthTech FundAlkemi Growth Capital+73 more
Redesigns industrial hardware to reduce friction wear and fugitive emissions, including the Callimorph actuator and Dragonfly stemless valve.
Co-investorsKero Development PartnersZero Carbon Capital
Data and image intelligence from the world's smallest untethered robots for hard-to-reach live infrastructure.
A UK-based company developing full-stack photonic quantum computers for applications in aerospace, cybersecurity, defence, energy, pharma and AI.
Deep TechQuantum ComputingSemiconductorsUK, GB
Scott Dufferwiel(Founder)in
Co-investorsCreative Destruction Lab (CDL)GIMIC Ventures
Digital health and telehealth company focused on AI-optimised remote physiotherapy.
Low-cost diagnostic tool for WHO-recommended diabetic eye screening with image interpretation.
Personalised wearable devices using computational design to create smart structures with varying stiffness.
AlgaeCytes cultivates microalgae using a patented photobioreactor system to produce sustainable, plant-based ingredients for dietary supplements, sports nutrition, cosmetics, pharmaceuticals, and agriculture.
BiotechFoodTech
Clinical-stage startup creating an advanced robotic colonoscopy system.
Developing a novel haematopoietic stem cell gene therapy.
arbnco offers an AI-powered platform for commercial real estate portfolios that accesses tenant energy consumption data, models building performance, and produces costed retrofit recommendations.
Climate TechEnergyPropTech
askRIA provides diligence infrastructure for private capital markets, offering AI agents that automate deal sourcing, evaluation, and portfolio monitoring across the funding lifecycle.
AI & Machine LearningEnterprise SoftwareFintech
Adhrita Nowrin(Founder)inadhrita nowrin
Co-investors500 Global
Medical device company developing AI-supported tracheostomy devices.
Atlas Endoscopy develops a robotic colonoscopy system for clinical use in diagnostic and therapeutic procedures.
HealthtechMedical DevicesRobotics
Production of medicinal-grade cannabis products.
Blossom Pharma is an EU-GMP certified contract manufacturer specializing in medical cannabis products, APIs, and narcotics, serving pharmaceutical and medical cannabis companies with end-to-end manufacturing services.
Advanced ManufacturingBiotechMedical Devices
BubblX develops AI-powered sensing technology that captures physiological signals and behavioral data from people in real-world settings.
AI & Machine LearningHealthtechRetail Tech
Butterfly Air makes indoor air quality (IAQ) monitoring devices — including the Morpho, Antenna, Sapho sensors and Chrysalis hub — that display air quality through colour-changing "gloWING" interfaces and a companion app with AI-driven personalised tips.
CleantechHardwareIoTChester, GB
UK digital health company providing a real-time scheduling and operational efficiency platform for hospitals.
Carocell Bio develops peptide-based anti-inflammatory therapeutics, including its lead peptide JEL0305, that inhibit the intracellular MAPK (p38) inflammatory pathway and are combined with a nanoparticle delivery technology for topical application to the skin.
BiotechDeep TechHealthtech
Mike Davies(CEO & Founder)Ashley George(Interim Chairman & Financial Director)
Checkboard offers a mobile app for identity verification, letting users verify their ID or complete payments and obtain a single reusable digital identity for use across multiple services.
CybersecurityFintechSaaS
Co-investorsBeringeaCornerstone VC
Healthcare technology solution designed to assist healthcare professionals in delivering personalised patient care
Healthcare technology assisting professionals in delivering personalised patient care.
Connect Childcare provides a comprehensive nursery management software system with integrated modules for staff administration, child development tracking, and parent communication, serving UK nurseries and childcare chains.
EdTechSaaS
Co-investorsGresham House Ventures
SaaS gamified social platform delivered via white-label website or app.
soloMER anti-inflammatory drug designed to be delivered to specific sites in the body.
Co-investorsScottish National Investment Bank
Develops novel high-performance enzymes using directed evolution molecular biology.
Co-investorsOxford Investment Opportunity Network (OION)
Solutions for training, rehabilitation and access for people with special education needs.
The Financial Ombudsman Service is a free UK public body, established by Parliament in 2001, that investigates complaints about financial businesses such as banks, insurers, pension and investment providers, and claims management companies.
FintechGovTech
Co-investorsForce Over Mass CapitalFuel VenturesO2h VenturesOxfordQVenturesSeneca Partners+1 more
Industrial coolant nano-fluids using graphene as the active ingredient.
Flexegraph develops graphene-based nanofluids for enhanced cooling and heat transfer in computers, data centers, energy systems, and automotive applications.
Advanced ManufacturingDeep TechNew Materials
'Butterfly' air quality management system delivering sensor data to consumers.
GeneralPractice.AI is a platform for primary care clinicians that generates personalized prevention and lifestyle medicine plans during routine consultations.
Digital HealthHealthtechSaaS
Diagnostics company developing ovarian cancer products on a platform for multiple applications.
Intelligent system combining biology and software to help people eat and live better.
GreyList uses Email Networking Analysis to trace financial assets and connections by analyzing email address interactions, identifying bank accounts, cryptocurrency accounts, and relationships between individuals.
Crypto & Web3Data & InfrastructureFintech
Next-generation dry metal-to-metal process for synthesising metallic nanoparticles.
Medical device company addressing idiopathic toe-walking in children.
HeadBox is a platform for planning and booking corporate meetings and events, pairing venue-sourcing software with a team of meetings and events experts.
Enterprise SoftwareMarketplacesSaaS
Co-investorsEgora HoldingEGORA Ventures AGGuinness VenturesSalica InvestmentsWild Blue Cohort
Cross-border e-commerce solutions enabling seamless customs clearance.
Technology for early detection of glaucoma and follow-up care.
AI to improve global interactions across healthcare, retail, hospitality and finance.
London, GB
Aleardo Furlani(Founder)
SaaS platform for client onboarding, AML and KYC services for property and finance.
Developing an innovative wellness and fitness technology with a global brand.
Quality therapeutic mattresses for the global market.
AI-driven autonomous compliance and risk management platform for industrial workplaces.
Microplate Dx develops rapid antibiotic susceptibility testing technology that detects bacterial growth and identifies species within 60 minutes, addressing antimicrobial resistance and urinary tract infections.
BiotechHealthtechMedical DevicesGlasgow, GB
Stuart Matthew Hannah(Director)
BoardPoonam Malik(Director)Andrew Justin Radcliffe Porter(Director)
HealthTech operating at the intersection of genomics, AI and machine learning.
Mumac, a University of Manchester spin-out, develops RapiDA, a digital screening process that uses patented dark adaptation technology to provide early detection of age-related macular degeneration (AMD) in about five minutes.
Digital HealthHealthtechMedical DevicesManchester, GB
Myma Medical develops autoICSI, an automation system for the ICSI (intracytoplasmic sperm injection) procedure used in IVF clinics, applying AI for gamete selection and automating gamete pickup and micro-manipulation.
AI & Machine LearningFemTechMedical Devices
New Path Molecular develops drug conjugates targeting phosphatidylserine on cancer cell membranes to treat solid tumors with reduced toxicity to healthy tissue.
BiotechMedical Devices
Co-investorsOxford Investment Opportunity Network (OION)
Ocutec is a life sciences company developing advanced materials and technologies for contact lenses and ophthalmic applications.
BiotechHealthtechMedical DevicesNew MaterialsScotland, GB
Scott Carnegie(Chairman and Finance Director)Stewart White(CEO)James H. Barton(Commercial Director)
Hand-held corneal topographer (OCUTOP) to diagnose eye conditions.
Pathfinder Med develops its patented ePATH catheter guidance platform for endovascular procedures in peripheral interventions and vascular access creation.
HardwareHealthtechMedical DevicesLondon, GB
Dr. Lorenzo Patrone(Chief Medical Officer)
Co-investorsCambridge Angels group
Conveyor belt technology to reduce cross-contamination risks in the food industry.
Automates R&D tax claims for early-stage life science companies.
Scalable pay-as-you-grow enterprise cloud management powered by OpenStack.
Technology to support school leaders and improve staff wellbeing and performance.
OnPulse technology platform proven to significantly improve blood flow.
Spotlight Pathology develops AI-based decision support software to assist pathologists in diagnosing blood cancers, integrating with existing digital pathology infrastructure to speed up diagnostic triage, automate cell counting, and improve objectivity of assessments.
AI & Machine LearningDigital HealthMedical Devices
Co-investorsUK Innovation & Science Seed Fund
STUNii is a mobile app and digital platform that connects students with exclusive offers, discounts, part-time jobs, and localized opportunities from partner brands across the UK.
B2B MarketplacesConsumerSocial
Value optimisation platform managing savings for enterprise technology contracts.
Innovative products addressing medical security needs for patients.
Technologies delivering innovative, personalised beauty experiences.
Wearable robotics with data analytics addressing musculoskeletal health.
Regenerative medicine company developing products to replace, repair and restore organs and tissues.
Digital veterinary triage platform offering 24/7 access to UK-registered vets.
VoxSmart provides communication capture and analysis solutions for financial services firms to meet regulatory requirements and extract trading insights from voice and text communications across multiple languages, regions, and devices.
AI & Machine LearningEnterprise SoftwareFintech
Co-investorsMaven Capital Partners
Next-generation cancer diagnostic devices delivering real-time results.
Portfolio news
latest coverage across their companiesFinancial Ombudsman · academyoflifeplanning.blog · Mar 16, 2026
Principals & officers · per Companies House
what is this? ⓘLLP designated member · since 2022
LLP member · since 2014
LLP member · since 2014
LLP member · since 2023
LLP member · since 2024
LLP member · since 2016
LLP member · since 2013
LLP member · since 2013
LLP member · since 2023
Corporate LLP member · since 2025
+2 more officers on the register
Ian Warwick — 75–100% of voting rights, right to share surplus assets 25 to 50 percent limited liability partnership
Frequently asked questions
- How many investments has Deepbridge Capital made?
- Deepbridge Capital has 97 tracked investments.
- What stage does Deepbridge Capital invest at?
- Deepbridge Capital invests at the Seed, Series A, Growth stages.
- What sectors does Deepbridge Capital focus on?
- Deepbridge Capital focuses on Advanced Manufacturing, AI & Machine Learning, Biotech, Cleantech, Climate Tech, Deep Tech, Digital Health, Energy, Fintech, Healthtech, IoT, Longevity, Medical Devices, Robotics, SaaS.
- Where is Deepbridge Capital located?
- Deepbridge Capital is headquartered in Chester, GB.
- Who does Deepbridge Capital co-invest with?
- Deepbridge Capital most often shares deals with Oxford Investment Opportunity Network (OION), Beringea, Force Over Mass Capital, among 25 tracked co-investors.
Media · Podcasts & interviews
featuring the teamDeepbridge Technology Growth EIS – 2017 interview with Ian Warwick, Deepbridge Capital
Wealth Club · Ian Warwick
BR Showcase 2019: Interview with Andrew Aldridge, Deepbridge Capital
Andrew Aldridge · vimeo.com
Ferryx Podcast
Deepbridge Capital LLP
Deepbridge Post Budget Webinar
Deepbridge Capital LLP
What does the future of EIS look like?
Deepbridge Capital LLP
What does Glyconics do?
Deepbridge Capital LLP
Similar investors
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
AddVentures is the corporate venture capital arm of SCG, one of the largest industrial conglomerates in Southeast Asia. It engages with tech startups worldwide through partnerships and investments, leveraging SCG's network and resources across the region.
BDC Fund Investments is the fund-of-funds arm of BDC Capital that acts as a limited partner, backing emerging and established fund managers who invest in technology-focused Canadian companies.



























